Bone morphogenetic protein-2 will be a novel biochemical marker in urinary tract infections and stone formation
Authors:
- Ragaa H.M. SalamaRSRagaa H.M. Salama
- Abdullah AlghashamAAAbdullah Alghasham
- Marwa S. MostafaMMMarwa S. Mostafa
- Alaa E.A. El-MoniemAEAlaa E.A. El-Moniem
- 1 July 2012
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 45 (10-11) , 766-769
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Circulating Bone Morphogenetic Protein 1–3 Isoform Increases Renal FibrosisJournal of the American Society of Nephrology, 2011
- Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitroKidney International, 2011
- Tamm-Horsfall Glycoprotein Interacts with Renal Outer Medullary Potassium Channel ROMK2 and Regulates Its FunctionJournal of Biological Chemistry, 2011
- Uromodulin Biology and Pathophysiology – An UpdateKidney and Blood Pressure Research, 2010
- Uromodulin-Associated Kidney DiseaseNephron Clinical Practice, 2010
- Crystallization of Calcium Oxalates Is Controlled by Molecular Hydrophilicity and Specific Polyanion-Crystal InteractionsLangmuir, 2009
- Genetic basis of renal cellular dysfunction and the formation of kidney stonesUrological Research, 2009
- Current concepts of molecular defence mechanisms operative during urinary tract infectionEuropean Journal of Clinical Investigation, 2008
- Serum Cystatin C-A Useful Endogenous Marker of Renal Function in Intensive Care Unit Patients at Risk for or with Acute Renal Failure?Current Medicinal Chemistry, 2007
- Measurement of cystatin-C and creatinine in urineClinica Chimica Acta, 2002